Published online before print June 13, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
*Department of Neurology and Interest Group in Neuro-Immune Interactions, SUNY Upstate Medical University, Syracuse, New York, USA; and Clinical and Experimental Endocrinology and Immunology, Wadsworth Center, Albany, New York, USA
@ To whom correspondence should be addressed. E-mail: massap{at}upstate.edu.
IL-33 is a novel member of the IL-1 cytokine family and a potent inducer of type 2 immunity, as mast cells and Th2 CD4+ T cells respond to IL-33 with the induction of type 2 cytokines such as IL-13. IL-33 mRNA levels are extremely high in the CNS, and CNS glia possess both subunits of the IL-33R, yet whether IL-33 is produced by and affects CNS glia has not been studied. Here, we demonstrate that pathogen-associated molecular patterns (PAMPs) significantly increase IL-33 mRNA and protein expression in CNS glia. Interestingly, IL-33 was localized to the nucleus of astrocytes. Further, CNS glial and astrocyte-enriched cultures treated with a PAMP followed by an ATP pulse had significantly higher levels of supernatant IL-1
and IL-33 than cultures receiving any single treatment (PAMP or ATP). Supernatants from PAMP + ATP-treated glia induced the secretion of IL-6, IL-13, and MCP-1 from the MC/9 mast cell line in a manner similar to exogenous recombinant IL-33. Further, IL-33 levels and activity were increased in the brains of mice infected with the neurotropic virus Theiler’s murine encephalomyelitis virus. IL-33 also had direct effects on CNS glia, as IL-33 induced various innate immune effectors in CNS glia, and this induction was greatly amplified by IL-33-stimulated mast cells. In conclusion, these results implicate IL-33-producing astrocytes as a potentially critical regulator of innate immune responses in the CNS.
Key Words: IL-1 family cytokines • IL-13 • astrocyte • pathogen-associated molecular pattern
This article has been cited by other articles:
 |
|
 |
|
  G E J Murphy, D Xu, F Y Liew, and I B McInnes Role of interleukin 33 in human immunopathology Ann Rheum Dis, January 1, 2010; 69(Suppl_1): i43 - i47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Talabot-Ayer, C. Lamacchia, C. Gabay, and G. Palmer Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage J. Biol. Chem., July 17, 2009; 284(29): 19420 - 19426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cayrol and J.-P. Girard The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 PNAS, June 2, 2009; 106(22): 9021 - 9026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Kuchler, J. Pollheimer, J. Balogh, J. Sponheim, L. Manley, D. R. Sorensen, P. M. De Angelis, H. Scott, and G. Haraldsen Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory Activation Am. J. Pathol., October 1, 2008; 173(4): 1229 - 1242. [Abstract] [Full Text] [PDF]
|
|
